Erythropoietin Receptor Activation by a Ligand-Induced Conformation Change
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Erythropoietin and other cytokine receptors are thought to be activated through hormone-induced dimerization and autophosphorylation of JAK kinases associated with the receptor intracellular domains. An in vivo protein fragment complementation assay was used to obtain evidence for an alternative mechanism in which unliganded erythropoietin receptor dimers exist in a conformation that prevents activation of JAK2 but then undergo a ligand-induced conformation change that allows JAK2 to be activated. These results are consistent with crystallographic evidence of distinct dimeric configurations for unliganded and ligand-bound forms of the erythropoietin receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
Dimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., & Ihle, J. N. (1993) · Cell · doi:10.1016/0092-8674(93)90414-l · Cited by 1,194
Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin
Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., & Dower, W. J. (1996) · Science · doi:10.1126/science.273.5274.458 · Cited by 672
Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599
Self-citationFunctional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Self-citationEfficiency of signalling through cytokine receptors depends critically on receptor orientation
Syed, R. S., Reid, S. W., Li, C., Cheetham, J. C., Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J., et al. (1998) · Nature · doi:10.1038/26773 · Cited by 551
Gadella, T. W., & Jovin, T. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.6.1543 · Cited by 438
The alphas, betas, and kinases of cytokine receptor complexes
Stahl, N., & Yancopoulos, G. D. (1993) · Cell · doi:10.1016/0092-8674(93)90506-l · Cited by 405
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
JAK-STAT Signaling: From Interferons to Cytokines
Schindler, C., Levy, D. E., & Decker, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700016200 · Cited by 1,258
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
TNF? and the TNF receptor superfamily: Structure-function relationship(s)
Idriss, H. T., & Naismith, J. H. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<184::aid-jemt2>3.0.co;2-h · Cited by 1,183
Takagi, J., Petre, B. M., Walz, T., & Springer, T. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00935-2 · Cited by 1,168
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
I nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,094
Atypical Membrane Topology and Heteromeric Function of Drosophila Odorant Receptors In Vivo
Benton, R., Sachse, S., Michnick, S. W., & Vosshall, L. B. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040020 · Cited by 1,015
Self-citationThe Myeloproliferative Disorders
Campbell, P. J., & Green, A. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra063728 · Cited by 915
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Activation of Downstream Signals by the Long Form of the Leptin Receptor
Banks, A. S., Davis, S. M., Bates, S. H., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14563 · Cited by 797
Protein–protein interactions define specificity in signal transduction
Pawson, T., & Nash, P. (2000) · Genes & Development · doi:10.1101/gad.14.9.1027 · Cited by 780
An in Vivo Map of the Yeast Protein Interactome
Tarassov, K., Messier, V., Landry, C. R., Radinovic, S., Molina, M. M. S., Shames, I., Malitskaya, Y., Vogel, J., Bussey, H., & Michnick, S. W. (2008) · Science · doi:10.1126/science.1153878 · Cited by 774
Self-citationErythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture
Gestwicki, J. E., Cairo, C. W., Strong, L. E., Oetjen, K. A., & Kiessling, L. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027184x · Cited by 706
Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599
Self-citationDimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
JAK/STAT signaling in hematological malignancies
Vainchenker, W., & Constantinescu, S. N. (2013) · Oncogene · doi:10.1038/onc.2012.347 · Cited by 528
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Tomato Ve disease resistance genes encode cell surface-like receptors
Kawchuk, L. M., Hachey, J., Lynch, D. R., Kulcsar, F., van Rooijen, G., Waterer, D. R., Robertson, A., Kokko, E., Byers, R., Howard, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091114198 · Cited by 464
Galarneau, A., Primeau, M., Trudeau, L.-E., & Michnick, S. W. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-619 · Cited by 410
Self-citationControl of Multivalent Interactions by Binding Epitope Density
Cairo, C. W., Gestwicki, J. E., Kanai, M., & Kiessling, L. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016727k · Cited by 383
Molecular Biology of Erythropoietin
JELKMANN, W. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.649 · Cited by 383
Erythropoietin after a century of research: younger than ever
Jelkmann, W. (2007) · European Journal of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 367
Ding, Y.-H., Baker, B. M., Garboczi, D. N., Biddison, W. E., & Wiley, D. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80080-1 · Cited by 363
Acharya, C., Coop, A., E. Polli, J., & D. MacKerell, A. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911793743547 · Cited by 340
Signaling pathways activated by the growth hormone receptor
Herrington, J. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00423-4 · Cited by 335
Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., & Jockers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200729200 · Cited by 322
Universal strategies in research and drug discovery based on protein-fragment complementation assays
Michnick, S. W., Ear, P. H., Manderson, E. N., Remy, I., & Stefan, E. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2311 · Cited by 319
Self-citationCytokine receptor signaling through the Jak–Stat–Socs pathway in disease
O'Sullivan, L. A., Liongue, C., Lewis, R. S., Stephenson, S. E. M., & Ward, A. C. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.025 · Cited by 308
New thrombopoietic growth factors
Kuter, D. J. (2007) · Blood · doi:10.1182/blood-2006-10-019315 · Cited by 307
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298
Chemically Controlled Protein Assembly: Techniques and Applications
Fegan, A., White, B., Carlson, J. C. T., & Wagner, C. R. (2010) · Chemical Reviews · doi:10.1021/cr8002888 · Cited by 294
Gilboa, L., Nohe, A., Geissendörfer, T., Sebald, W., Henis, Y. I., & Knaus, P. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.1023 · Cited by 291
van der Merwe, P. A., Davis, S. J., Shaw, A. S., & Dustin, M. L. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0203 · Cited by 290
New Thrombopoietic Growth Factors
Kuter, D. J. (2009) · Clinical Lymphoma and Myeloma · doi:10.3816/clm.2009.s.034 · Cited by 285
The biology of thrombopoietin and thrombopoietin receptor agonists
Kuter, D. J. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1382-0 · Cited by 285
Monomeric and Oligomeric Complexes of the B Cell Antigen Receptor
Schamel, W. W. A., & Reth, M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00003-0 · Cited by 278
Constantinescu, S. N., Keren, T., Socolovsky, M., Nam, H.-S., Henis, Y. I., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081069198 · Cited by 260
Structural evidence for dimerization-regulated activation of an integral membrane phospholipase
Snijder, H. J., Ubarretxena-Belandia, I., Blaauw, M., Kalk, K. H., Verheij, H. M., Egmond, M. R., Dekker, N., & Dijkstra, B. W. (1999) · Nature · doi:10.1038/401717a0 · Cited by 257
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business
Mogensen, K. E., Lewerenz, M., Reboul, J., Lutfalla, G., & Uzé, G. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313019 · Cited by 252
Bunn, H. F. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011619 · Cited by 234
Remy, I., & Michnick, S. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5394 · Cited by 231
Self-citationNEW EMBO MEMBERS' REVIEW: Receptor recognition by gp130 cytokines
Bravo, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2399 · Cited by 211
Thompson, T. B. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg156 · Cited by 210
GENETIC DISORDERS OF PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM
Bidère, N., Su, H. C., & Lenardo, M. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090513 · Cited by 197
Stefan, E., Aquin, S., Berger, N., Landry, C. R., Nyfeler, B., Bouvier, M., & Michnick, S. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704257104 · Cited by 192
Self-citationConstantinescu, S. N., Huang, L. J.-S., Nam, H.-S., & Lodish, H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00185-x · Cited by 178
Vallée-Bélisle, A., Ricci, F., & Plaxco, K. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904005106 · Cited by 177
Structure of IL-22 Bound to Its High-Affinity IL-22R1 Chain
Jones, B. C., Logsdon, N. J., & Walter, M. R. (2008) · Structure · doi:10.1016/j.str.2008.06.005 · Cited by 175
“Based on mechanistic studies of growth hormone and erythropoietin signaling, binding of IL-22 and IL-10 to their respective R1/R2 heterodimers is expected to induce rotational and/or conformational changes in the receptors leading to cell signaling (Brown et al., 2005; Remy et al., 1999).”
BackgroundThe Leptin Receptor Complex: Heavier Than Expected?
Wauman, J., Zabeau, L., & Tavernier, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00030 · Cited by 174
Noninvasive imaging of protein–protein interactions in living animals
Luker, G. D., Sharma, V., Pica, C. M., Dahlheimer, J. L., Li, W., Ochesky, J., Ryan, C. E., Piwnica-Worms, H., & Piwnica-Worms, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092022399 · Cited by 161
Small-Molecule Trk Agonists: Where Do We Go from Here?
Thompson, T. S., Sefiani, A., & Burgess, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02365 · Cited by 13
“37 Epidermal growth factor (EGF) is unlike the NTs insofar as two EGF molecules bind outside EGFR dimers giving receptor activation; 38 furthermore, binding triggers a conformational shift in the extracellular region, allowing the monomeric receptor to dimerize and activate (1b, center).”
Lamon, S., Zacharewicz, E., Arentson-Lantz, E., Gatta, P. A. D., Ghobrial, L., Gerlinger-Romero, F., Garnham, A., Paddon-Jones, D., & Russell, A. P. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00292 · Cited by 10
“As the EPOmolecule binds to its receptor, it induces a conformational change that activates the EPOR (Miura et al., 1991; Dusanter-Fourt et al., 1992) via the phosphorylation of the JAK2 protein (Constantinescu et al., 1999; Remy et al., 1999).”
BackgroundTargeting Immune Signaling Pathways in Clonal Hematopoiesis
Azrakhsh, N. A., Mensah-glanowska, P., Sand, K., & Kittang, A. O. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190325100636 · Cited by 8
Metadata
- Authors
- Remy, I., Wilson, I. A., & Michnick, S. W.
- Venue
- Science
- Published
- 1999-02-12
- Volume
- 283
- Issue
- 5404
- Pages
- 990-993
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061776631
- Cited by
- 634
- References
- 19
- FWCI
- 26.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.